Skip to content

Clinical trials

Diabetic Nephropathies trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetic Nephropathies Country / region: China Clear all

65 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20061
20072
20091
20101
20112
20131
20142
20153
20175
20181
20192
20204
202112
20226
20235
20245
20256
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24
Unknown status20
Recruiting11
Not yet recruiting6
Active, not recruiting3
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chinese PLA General Hospital4
Yipeng Liu3
Bayer2
Liu Hongfang2
Second Affiliated Hospital, Zhejiang University, School of Medicine2
Second Xiangya Hospital of Central South University2
Shanghai Jiao Tong University School of Medicine2
Shanghai Pudong Hospital2
Alebund Pharmaceuticals1
Asia Diabetes Foundation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetic Nephropathies65
Diabetes Mellitus, Type 217
Renal Insufficiency, Chronic6
Kidney Diseases5
Albuminuria3
Diabetes Mellitus3
Glomerulonephritis, IGA3
Glomerulonephritis, Membranous3
Proteinuria3
Glomerulosclerosis, Focal Segmental2

Trials

Showing 51 to 65 of 65. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.